Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Abstract Background Second allogeneic hematopoietic stem cell transplant (HCT) remains as an option for disease relapse after initial HCT. Methods We analyzed retrospectively the outcomes of 65 consecutive patients who underwent a second HCT for disease relapse at the University of Chicago. Univaria...

詳細記述

書誌詳細

出版年:	Experimental Hematology & Oncology
主要な著者:	Yun Fan, Andrew S. Artz, Koen van Besien, Wendy Stock, Richard A. Larson, Olatoyosi Odenike, Lucy A. Godley, Justin Kline, John M. Cunningham, James L. LaBelle, Michael R. Bishop, Hongtao Liu
フォーマット:	論文
言語:	英語
出版事項:	BMC 2019-01-01
主題:	Second allogeneic bone marrow transplantation T cell depletion Non-relapse mortality
オンライン･アクセス:	http://link.springer.com/article/10.1186/s40164-018-0125-6